1 mg semaglutide to tirzepatide vs Semaglutide: Complete Comparison Tirzepatide vs Semaglutide for Weight

The basics still matter most

In some clinical trials, patients who received Semaglutide GLP-1 lost an average of 14.9% of their body weight over 68 weeks and experienced a reduction in waist circumference and visceral adipose tissue

The increased risk of disease is related to the decrease of prognosis and survival rate

After 28 days, potency begins to decline and bacterial contamination risk increases beyond acceptable levels

However, human thyroid tissue has significantly fewer GLP-1 receptors on C-cells compared to rodent thyroid tissue, which likely explains why this risk has not materialized in human clinical data